NASDAQ: JAGX · Life Sciences · 12 alerts · CIK 1585608
Share price
$0.3864Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Jaguar Health, Inc. filings on SEC EDGAR ↗
Jaguar Health $3.4M Debt Financing with Streeterville Capital, LLC
Jaguar Health entered into exchange agreements with Streeterville Capital to reduce the outstanding balance of a 2021 secured promissory note by $3.4 million. In exchange for this debt reduction, the company issued 481,584 shares of its common stock to the lender. The transaction was conducted as a privately negotiated exchange exempt from registration under Section 3(a)(9) of the Securities Act.
Jaguar Health $6.73M Debt Financing with Streeterville Capital, LLC
Jaguar Health entered into exchange agreements with Streeterville Capital to reduce its outstanding debt by approximately $6.73 million through the issuance of common stock. Specifically, the company issued 182,091 shares to reduce a 2021 note by $1.68 million and 547,898 shares to fully pay off and cancel a 2025 note valued at $5.05 million.
Jaguar Health $5.05M Debt Financing with Streeterville Capital, LLC
Jaguar Health entered into exchange agreements with Streeterville Capital to reduce the outstanding balance of a 2025 secured promissory note by approximately $5.05 million. In exchange for this debt reduction, the company issued 547,898 shares of common stock to the lender. This transaction effectively settles a portion of the company's existing debt obligations through equity issuance.